Selected Publications

Vogtherr M, Saxena K, Hoelder S, Grimme S, Betz M, Schieborr U, Pescatore B, Robin M, Delarbre L, Langer T, Wendt KU, Schwalbe H. NMR characterization of kinase p38 dynamics in free and ligand-bound forms. Angew Chem Int Ed Engl 2006; 45(6):993-997.

Hoelder S, Schöenafinger K, Will D, Matter H, Mueller H, Bossart M, Combeau C, Delaisi C, Steinmetz A, Sassoon I. Novel Pyridazinone Derivatives as Inhibitors of CDK2. PCT Int Appl 2005; WO 2005111019.

Hoelder S, Schönafinger K, Will D, Matter H, Müller H, Bossart M, Combeau C, Delaisi C, Steinmetz A, Sassoon I. Novel 4-Benzimidazol-2-YLPyridazin-3-one derivatives. PCT Int Appl 2005; WO2005085231.

Hoelder S, Naumann T, Schoenafinger K, Will D, Matter H, Mueller G, Lesuisse D, Baudoin B, Rooney T, Halley F, Tiraboschi G, Combeau C, Steinmetz A. Pyridazinone Derivatives as Inhibitors of CDK2. PCT Int Appl 2004; WO2004046130.

Petry S, Baringhaus K-H, Hoelder S, Mueller G. Preparation of substituted and non-substituted benzooxathiazoles and compounds derived therefrom. PCT Int Appl 2002; WO 2002011722.